argenx SE (STU:1AE)
€ 553.6 6 (1.1%) Market Cap: 33.43 Bil Enterprise Value: 30.56 Bil PE Ratio: 0 PB Ratio: 8.44 GF Score: 82/100

Q2 2023 argenx SE Earnings Call Transcript

Jul 27, 2023 / 12:30PM GMT
Release Date Price: €469 (-1.43%)
Operator

Good morning. My name is Sarah, and I will be your conference operator today. I would like to welcome everyone to the call. (Operator Instructions).

Thank you. I'd like to introduce Bell -- sorry, Beth DelGiacco, Vice President, Global Head of Corporate Communications and Investor Relations. You may now begin your conference.

Beth DelGiacco
argenx SE - VP and Global Head of Corporate Communications & IR

Thank you, operator. A press release was issued earlier today, with our half year 2023 financial results and the second quarter business update. This can be found on our website, along with the presentation for today's webcast. Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones.

Actual results may differ materially from those indicated by these statements. Argenx is not under

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot